Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
“The global market opportunity for Cannabis is rapidly growing,and projected to reach over $30 billion according to recent studies. The need for safer and more effective routes of administration remains unmet. The Company believes its technology is well positioned to help solve this problem and intends to seek commercialization partners for the eluting patch technology in the United States and globally. The Greater Cannabis Company’s technology is protected by multiple global issued patents under its license with Pharmedica, an Israeli-based biopharmaceutical company. The Company intends to submit additional patent applications, which are currently in process.”
http://globenewswire.com/news-release/2018/10/11/1620215/0/en/The-Greater-Cannabis-Company-Files-Additional-Patent-to-Further-Protect-Proprietary-Cannabinoid-Delivery-System.html
$GCAN~Canadian Cannabis CBD co. w/ patented tech & approx 30 mil O/S.
https://www.otcmarkets.com/stock/GCAN/overview
http://globenewswire.com/news-release/2018/10/11/1620215/0/en/The-Greater-Cannabis-Company-Files-Additional-Patent-to-Further-Protect-Proprietary-Cannabinoid-Delivery-System.html
https://www.sec.gov/Archives/edgar/data/1695473/000149315218010899/ex10-36.htm
Annex B – Patent(s)/Patent Application(s)
1. WO 2012/104834 A1
New oral dissolving films for insulin administration, for treating diabetes.
filed on December 2011. National Phase at Israel and the USA.
2. WO 2010/135053 A2
Dual and single layer dosage forms.
Issued USA patent on April 28, 2015.
3. PCT/IL 2017/050845
Adhesive Oral dissolved Films in Managing Oral Care.
PCT on 31 July 2017.
https://globenewswire.com/news-release/2018/10/04/1601401/0/en/The-Greater-Cannabis-Company-Appoints-Dr-Hock-Tan-as-Chairman-of-Scientific-Advisory-Board.html
http://bionexpharma.com/Management.aspx
https://www.google.com/amp/s/www.cnbc.com/amp/2018/08/06/globe-newswire-the-greater-cannabis-company-inc-acquires-cannabis-biotech-green-c-corporation-through-a-share-exchange-agreement.html
The Company will be submitting its application in the coming weeks to OTC Markets to be uplisted to the OTCQB.”
http://www.pharmedica.co.il/
https://www.otcmarkets.com/stock/GCAN/news/story?e&id=1178022
$GCAN~Canadian Cannabis CBD co. w/ patented tech & approx 30 mil O/S.
https://www.otcmarkets.com/stock/GCAN/overview
http://globenewswire.com/news-release/2018/10/11/1620215/0/en/The-Greater-Cannabis-Company-Files-Additional-Patent-to-Further-Protect-Proprietary-Cannabinoid-Delivery-System.html
https://www.sec.gov/Archives/edgar/data/1695473/000149315218010899/ex10-36.htm
Annex B – Patent(s)/Patent Application(s)
1. WO 2012/104834 A1
New oral dissolving films for insulin administration, for treating diabetes.
filed on December 2011. National Phase at Israel and the USA.
2. WO 2010/135053 A2
Dual and single layer dosage forms.
Issued USA patent on April 28, 2015.
3. PCT/IL 2017/050845
Adhesive Oral dissolved Films in Managing Oral Care.
PCT on 31 July 2017.
https://globenewswire.com/news-release/2018/10/04/1601401/0/en/The-Greater-Cannabis-Company-Appoints-Dr-Hock-Tan-as-Chairman-of-Scientific-Advisory-Board.html
http://bionexpharma.com/Management.aspx
https://www.google.com/amp/s/www.cnbc.com/amp/2018/08/06/globe-newswire-the-greater-cannabis-company-inc-acquires-cannabis-biotech-green-c-corporation-through-a-share-exchange-agreement.html
The Company will be submitting its application in the coming weeks to OTC Markets to be uplisted to the OTCQB.”
http://www.pharmedica.co.il/
https://www.otcmarkets.com/stock/GCAN/news/story?e&id=1178022
$GCAN~Canadian Cannabis CBD co. w/ patented tech & approx 30 mil O/S.
https://www.otcmarkets.com/stock/GCAN/overview
http://globenewswire.com/news-release/2018/10/11/1620215/0/en/The-Greater-Cannabis-Company-Files-Additional-Patent-to-Further-Protect-Proprietary-Cannabinoid-Delivery-System.html
https://www.sec.gov/Archives/edgar/data/1695473/000149315218010899/ex10-36.htm
Annex B – Patent(s)/Patent Application(s)
1. WO 2012/104834 A1
New oral dissolving films for insulin administration, for treating diabetes.
filed on December 2011. National Phase at Israel and the USA.
2. WO 2010/135053 A2
Dual and single layer dosage forms.
Issued USA patent on April 28, 2015.
3. PCT/IL 2017/050845
Adhesive Oral dissolved Films in Managing Oral Care.
PCT on 31 July 2017.
https://globenewswire.com/news-release/2018/10/04/1601401/0/en/The-Greater-Cannabis-Company-Appoints-Dr-Hock-Tan-as-Chairman-of-Scientific-Advisory-Board.html
http://bionexpharma.com/Management.aspx
https://www.google.com/amp/s/www.cnbc.com/amp/2018/08/06/globe-newswire-the-greater-cannabis-company-inc-acquires-cannabis-biotech-green-c-corporation-through-a-share-exchange-agreement.html
The Company will be submitting its application in the coming weeks to OTC Markets to be uplisted to the OTCQB.”
http://www.pharmedica.co.il/
https://www.otcmarkets.com/stock/GCAN/news/story?e&id=1178022
Buy em up ;).
With this tiny float they showed their hand early around .10. They obviously don’t want to give back to many shares down here. I’ll be adding more. Imo.
$GCAN
Yup need big collateral I get that. That’s why only the big boys play that game. I’ll know what I know and you do the same. Gltu
That’s why they make money on the way up. You didn’t even know this was a frickin’ ipo lol. Naked shorting happens all the time on the otc. Be blind to the game it’s fine. Geez...
Bs you don’t need big volume to manipulate a stock.
Big accts naked short to accumulate otc stocks. They make money on the way up. Happens all the time. Eom
Much better than a cbd beverage that anyone can produce. Cbd patents will be like gold. Imo
$GCAN
“The Company will be submitting its application in the coming weeks to OTC Markets to be uplisted to the OTCQB.”
https://www.sec.gov/Archives/edgar/data/1695473/000149315218010899/ex10-36.htm
Annex B – Patent(s)/Patent Application(s)
1. WO 2012/104834 A1
New oral dissolving films for insulin administration, for treating diabetes.
filed on December 2011. National Phase at Israel and the USA.
2. WO 2010/135053 A2
Dual and single layer dosage forms.
Issued USA patent on April 28, 2015.
3. PCT/IL 2017/050845
Adhesive Oral dissolved Films in Managing Oral Care.
PCT on 31 July 2017.
https://globenewswire.com/news-release/2018/10/04/1601401/0/en/The-Greater-Cannabis-Company-Appoints-Dr-Hock-Tan-as-Chairman-of-Scientific-Advisory-Board.html
http://bionexpharma.com/Management.aspx
https://www.google.com/amp/s/www.cnbc.com/amp/2018/08/06/globe-newswire-the-greater-cannabis-company-inc-acquires-cannabis-biotech-green-c-corporation-through-a-share-exchange-agreement.html
http://www.pharmedica.co.il/
https://www.otcmarkets.com/stock/GCAN/news/story?e&id=1178022
Agree. This patch platform may become the best cbd delivery system available for consumers! Can make a retail and medical one. Will be huge! Imo.
$GCAN
This board is littered with shorts groupies. Heavy loading I see. Turning point of the company and cheap equity?! I’ll grab a few. Glta
They want your shares bad. Lock em up on gtc. With this tiny float this one can fly. Eom
$GCAN
Glad I found this stock. Moves like it will be dollars in no time.
$GCAN
Nice! Thanks :) $GCAN
https://www.sec.gov/Archives/edgar/data/1695473/000149315218010899/ex10-36.htm
Annex B – Patent(s)/Patent Application(s)
1. WO 2012/104834 A1
New oral dissolving films for insulin administration, for treating diabetes.
filed on December 2011. National Phase at Israel and the USA.
2. WO 2010/135053 A2
Dual and single layer dosage forms.
Issued USA patent on April 28, 2015.
3. PCT/IL 2017/050845
Adhesive Oral dissolved Films in Managing Oral Care.
PCT on 31 July 2017.
This stock is headed to pennies when suppression ends and/or news hits. Is undervalued and will be even more so once a few of the news pieces we’re waiting for come out. Prob a ten bagger here. Imo. $VRUS
Wrong players. Lol
Buy em up ;).
$GCAN
Helps to know even just a few of the players and the game. $GCAN
Eom
Naw. ;). $GCAN
Buy em up. $GCAN
Great post! Yup “Building a better mouse trap” ;) and set up a world wide license agreement. Weee love CBD and $$!
Who knows maybe another 200% next week. She’s got wheels.
$GCAN
https://globenewswire.com/news-release/2018/10/04/1601401/0/en/The-Greater-Cannabis-Company-Appoints-Dr-Hock-Tan-as-Chairman-of-Scientific-Advisory-Board.html
http://bionexpharma.com/Management.aspx
https://www.google.com/amp/s/www.cnbc.com/amp/2018/08/06/globe-newswire-the-greater-cannabis-company-inc-acquires-cannabis-biotech-green-c-corporation-through-a-share-exchange-agreement.html
http://www.pharmedica.co.il/
https://www.otcmarkets.com/stock/GCAN/news/story?e&id=1178022
$GCAN
Locked at 20 $$. Eom
$$$GCAN
Oh yeah. Shorts playin’ a game of accumulation here but with such a small float they’ve been workin’ hard. ;)
Imo
Yup moves and consolidates fast with the low float. Buy what you can and hold on tight. Imo
$GCAN
Agree. I really like Tan! Bringing on the big guns and setting the foundation for big product(s) PR. Imo
$GCAN
Yeah that will be GREAT! #Superstore
Lock all your shares up on a gtc.
$GCAN
Knew this had legs. Holding for 10-20 bucks. Imo $GCAN
Yeah that’s what I’m thinking. Billions about to flow into the industry. Mj mania will come! Nice job on the shares!
$GCAN
Merger Ipo Cannabis stock with an amazing SS, worldwide license agreement and a superstore.
Interested to find out more about Green C $$$$!
News a comin’!
$GCAN
The Greater Cannabis Company, Inc. Acquires Cannabis Biotech Green C Corporation through a Share Exchange Agreement
Published 12:24 PM ET Mon, 6 Aug 2018
Globe Newswire
ST. PETERSBURG, FL, Aug. 06, 2018 (GLOBE NEWSWIRE) -- The Greater Cannabis Company, Inc. (OTC Pink: GCAN) (“the Company”) is pleased to announce that it has acquired Green C Corporation through a Share Exchange Agreement dated July 31, 2018.
On July 31, 2018, the Company and Green C Corporation (Green C”) closed on a Share Exchange Agreement whereby the Company issued to the holders of Green C’s common stock a newly designated Preferred Stock titled Series A Convertible Preferred Stock (“Series A”) for all of the issued, and outstanding shares of common stock of Green C. Upon closing, Green C became a wholly owned subsidiary of the Company. Further details of the transaction can be found in the Company’s 8-K filed with the Securities and Exchange Commission at www.sec.gov.
Green C is a Canadian company focused on innovative drug delivery systems for the Cannabis industry and has an exclusive worldwide license for PharMedica’s “Eluting Transmucosal Patch Platform (ETP)” for non-invasive drug delivery for use in the Cannabis field. Some of the major advantages to the drug delivery platform include its rapid onset or slow, controlled and sustained release delivery capabilities. Green C has leveraged the ETP technology to manufacture a controlled and sustained release dose of Cannabinoids all on one oral patch.
As part of the transaction, the existing directors of GCAN will be stepping down and new directors and officers will be appointed. Mr. Aitan Zacharin, former founder and director of Fuse Science and an experienced public biotech executive, will be leading the Company as its CEO. Mr. Mark Radom will serve as the Company’s chief legal officer, and corporate counsel. “I am honored and excited to be leading GCAN as a biotechnology innovator in the Cannabis space,” said Mr. Zacharin. “We have licensed a technology that comes from decades of research and development of a novel delivery system, which improves drug bioavailability with improved efficacy.” “I look forward to working with our team in an effort to bring this important innovation to the global Cannabis market, and address a real unmet need for millions of patients.”
The Company is pleased to announce that its common stock is now quoted under the symbol “GCAN.” The Company’s market capitalization consists of 29,580,969 outstanding shares, and 10 million shares of authorized preferred stock as of July 31, 2018. Upon receipt of the date stamped designation of the newly formed Series A, the Company will issue 10,000,000 shares of the Series A to the former Green C shareholders.
The Company will be submitting its application in the coming weeks to OTC Markets to be uplisted to the OTCQB.
Outgoing director of GCAN, Wayne Anderson, had this to say about the transaction, “I wish to thank our loyal shareholders who have been exceptionally patient during the process of publicly listing GCAN. We have exhausted numerous hours completing our due diligence on the best path for GCAN in the Cannabis sector. We are confident that Green C’s drug delivery technology licensed from Pharmedica coupled with their stellar management team will lead GCAN to be a leader and innovator in the rapidly growing Cannabis industry. I look forward to working with the new management team over the next month as Green C transitions into GCAN and takes the helm.”
About Green C Corporation
Green C is a Canadian company focused on innovative delivery systems for the Cannabis industry and has the exclusive worldwide license for PharMedica’s Eluting Transmucosal Patch Platform (ETP) for non-invasive drug delivery for use in the Cannabis field. The company holds the rights to new delivery technologies using a bio-adhesive, adjustable dose, and fully dissolvable, non-irritant patch, which provides for a needle free, intra-oral systemic drug delivery. The conveyance technology is designed to accelerate and enhance the delivery and bioavailability of medicines and nutraceuticals when compared to traditional methods of enteral administration.
About The Greater Cannabis Company, Inc.
The Greater Cannabis Company, Inc. was formed in March 2014 as a limited liability company under the name, The Greater Cannabis Company, LLC. The Company remained a wholly owned subsidiary of Sylios Corp until March 2017. The Company’s business plan is to concentrate on cannabis related investment and development opportunities through its direct equity investments, joint ventures, licensing agreements, or acquisitions. Further information can be found on the Company’s website at www.greatercannabiscompany.com.
Forward Looking Statements and Disclaimer
Statements made in this press release that express the Company or management's intentions, plans, beliefs, expectations or predictions of future events, are forward-looking statements. The words "believe," "expect," "intend," "estimate," "anticipate," "will" and similar expressions are intended to further identify such forward-looking statements, although not all forward-looking statements contain these identifying words. Those statements are based on many assumptions and are subject to many known and unknown risks, uncertainties and other factors that could cause the Company's actual activities, results or performance to differ materially from those anticipated or projected in such forward-looking statements. The Company cannot guarantee future financial results; levels of activity, performance or achievements and investors should not place undue reliance on the Company's forward-looking statements. No information contained in this press release should be construed as any indication whatsoever of the Company's future financial performance, future revenues or its future stock price. The forward-looking statements contained herein represent the judgment of the Company as of the date of this press release, and the Company expressly disclaims any intent, obligation or undertaking to update or revise such forward-looking statements to reflect any change in the Company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based. No information in this press release should be construed as any indication whatsoever of the Company's future revenues or results of operations. Additional risks and uncertainties are set forth in the Company's Annual Report for the year ended December 31, 2017, which can be found on the Securities and Exchange Commission’s website at www.sec.gov as well as on the Company’s website at www.greatercannabiscompany.com.
Contact: The Greater Cannabis Company, Inc. 443-738-4051 info@greatercannabiscompany.com
Source: TheGreater Cannabis Company, Inc.
https://www.google.com/amp/s/www.cnbc.com/amp/2018/08/06/globe-newswire-the-greater-cannabis-company-inc-acquires-cannabis-biotech-green-c-corporation-through-a-share-exchange-agreement.html
All short selling to accumulate right now. With the low float everyone needs to be locking up their shares. Going to be a monster. Imo. Eom
$GCAN
“They” want your shares! ;)
M&A and ticker change coming it sounds to me.
#NotGettingMine
$VRUS
Some have a hard time believing that there are hedge “groups” that manipulate good stocks to accumulate them by naked shorting. Eom
Cover em up. Eom
$VRUS
Wow two M&A prospects just weeks away. Name change coming soon. Financing deals being set up. Products rolling out. Looking good here. $VRUS
Name change soon > news in regards to $$ and shipping > golden Cross.
They have big goals in the near future per their presentation. I’ll wait for a few of the catalysts to come. There is no way they are planning all this to go stagnant. It’s Coming!
Oversold and Undervalued.
Imo
$VRUS